News & Trends - MedTech & Diagnostics
New partnership to tackle rheumatic heart disease in First Nations communities
Acute rheumatic Fever (ARF) and rheumatic heart disease (RHD) are preventable diseases triggered by a bacterial streptococcal infection with lifelong impact. In addressing health disparities in Australia, the National Aboriginal Community Controlled Health Organisation (NACCHO) and The Snow Foundation have partnered to prevent these diseases in remote Aboriginal and Torres Strait Islander communities.
The nation continues to record some of the highest rates of RHD globally, according to the latest Australian Institute of Health and Welfare (AIHW) report. This disease disproportionately affects Aboriginal and Torres Strait Islander people who may requires lifelong care, including many years of preventive antibiotics and, sometimes, invasive cardiac surgery.
The Snow Foundation’s grant of $1 million ($500,000 annually for an initial two years) will expand NACCHO’s ARF and RHD Prevention Program into more Aboriginal and Torres Strait Islander Community Controlled Organisations and their communities. This strategic two-year investment aims to bolster the broader Aboriginal Community Controlled Health Sector, enabling it to scale up efforts to prevent and manage these devastating yet preventable diseases.
“As Australia’s peak community-controlled body for Aboriginal and Torres Strait Islander peoples’ health and wellbeing, NACCHO acknowledges The Snow Foundation as one of the first in Australia to support community-controlled program design and delivery. We all have a part to play in closing the gap,” Dr Dawn Casey, CEO of NACCHO said.
Without immediate and decisive action led by Aboriginal and Torres Strait Islander people, these numbers are projected to double within the next decade.
In an interview with Health Industry Hub, former Roche Diagnostics Managing Director, Allison Rossiter, delved into the health inequities impacting First Nations people, including the pressing issue of rheumatic heart disease. Working alongside the three experts, the company is co-designing an Indigenous-led solution to tackle this disease.
The NACCHO partnership builds on The Snow Foundation’s 13-year focus on Aboriginal and Torres Strait Islander health. It reflects the shared values of listening to and supporting Aboriginal and Torres Strait Islander leaders, communities, and strengths-based programs focusing on self-determination and sustainability.
More recently The Snow Foundation’s focus has been on community-led programs including Champions for Change, Orange Sky laundries, and initiatives that facilitate community outreach by paediatric cardiologists and their multidisciplinary specialist teams.
“NACCHO are the experts in Aboriginal health and wellbeing, driving community-led initiatives where the power and decision-making are in Aboriginal communities’ hands. We have seen firsthand that this achieves better outcomes,” Georgina Byron, CEO of The Snow Foundation said.
“We’re delighted to partner with NACCHO and see the importance of backing Aboriginal leadership and ensuring Aboriginal health is controlled by Aboriginal people and communities. This partnership re-affirms the principles of self-empowerment and self-determination that will achieve more impact through community-led strategies.”
The partnership between NACCHO and The Snow Foundation is an example of the collaborative effort required to meet the government’s commitment to eradicate new cases of RHD by 2030.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]
MoreNews & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
More